# Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

> **NCT03462615** · — · UNKNOWN · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 930 (estimated)

## Conditions studied

- Plasmodium Falciparum Malaria
- Pregnancy Malaria
- Diagnoses Disease

## Interventions

- **DIAGNOSTIC_TEST:** HS-RDT

## Key facts

- **NCT ID:** NCT03462615
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 930 (ESTIMATED)
- **Last updated:** 2018-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03462615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03462615, "Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03462615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*